Clinical Trials
4 trialsNCT02876107 2026-04-15
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT02411656 2026-01-23
Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT05142800 2025-05-22
Screening For BCRL In Targeted Therapy For Breast Cancer
Massachusetts General Hospital
Active not recruiting
NCT02306538 2023-02-14
EMBRACE-MRI
University Health Network, Toronto
Active not recruiting